Market Tracker

02/20 3:37am ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

371.18
Delayed Data
As of Feb 17
 -1.84 / -0.49%
Today’s Change
325.35
Today|||52-Week Range
452.96
+1.11%
Year-to-Date
Amgen Shows a Bullish Breakout
Feb 16 / TheStreet.com - Paid Partner Content
A Big Corporate Tax Boost for Big Spenders?
Feb 14 / TheStreet.com - Paid Partner Content
Bullish Momentum for Regeneron
Feb 15 / TheStreet.com - Paid Partner Content
3 Beaten-Down Stocks Ready to Bounce Back
Feb 10 / MotleyFool.com - Paid Partner Content
Drug Stocks Q4 Earnings Slated for Feb 16: ALXN, ZTS & More
Feb 15 / Zacks.com - Paid Partner Content
Regeneron (REGN) Misses on Q4 Earnings & Sales, View Bleak
Feb 09 / Zacks.com - Paid Partner Content
Amgen Looking to Broaden Leukemia Drug Blincyto's Label
Feb 15 / Zacks.com - Paid Partner Content
Regeneron (REGN) Q4 Earnings Misses Estimates
Feb 09 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Regeneron's Praluent to Remain on Market for Now, GILD Present...
Feb 15 / Zacks.com - Paid Partner Content
Regeneron (REGN) Q4 Earnings: Will the Stock Disappoint?
Feb 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close373.02
Today’s open372.42
Day’s range369.30 - 375.00
Volume775,547
Average volume (3 months)950,983
Market cap$39.4B
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+39.49%
Earnings growth (this year)+19.52%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+18.44%
P/E ratio48.2
Price/Sales8.79
Price/Book8.84

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-1.57-1.20%
BAXBaxter International...+0.31+0.63%
ZTSZoetis Inc-0.27-0.51%
SHPGShire+2.38+1.33%
Data as of 4:01pm ET, 02/17/2017

Financials

Next reporting dateMay 5, 2017
EPS forecast (this quarter)$3.10
Annual revenue (last year)$4.9B
Annual profit (last year)$895.5M
Net profit margin18.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Scientific Officer
George Damis Yancopoulos
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts